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Abstract
Background and objectives: Various cereals, fruits, and vegetables are commonly 
contaminated with mycotoxins such as zearalenone (ZEN), alternariol (AOH), and 
alternariol monomethyl ether (AME). More recently, their glucosidic metabolites 
formed in the plant have gained increasing attention. Experimental data on the con-
tribution of modified mycotoxins to total toxicity are either controversy or lacking. 
Thus, the aim of this study was to investigate the absorption and metabolism of 
ZEN-, AOH-, and AME-glucosides using the Caco-2 cell system.
Findings: No quantifiable amounts of ZEN-14-glucoside, ZEN-16-glucoside, free 
ZEN, and ZEN metabolites were found in Caco-2 cells and in the basolateral com-
partment. In contrast, glucosides of AOH and AME were absorbed and released their 
parental toxins, which were further metabolized to form glucuronides and sulfates to 
a variable extent. Metabolites were found on the basolateral site, too. There is also 
evidence that AOH-9-diglucoside is hydrolyzed to AOH-9-glucoside.
Conclusion: Our results demonstrate that modified ZEN is less absorbed whereas 
modified Alternaria toxins are taken up to a higher extent by Caco-2 cells, followed 
by deglucosylation, metabolization, and transport to the basolateral site, suggesting a 
potential contribution to overall toxicity of these modified mycotoxins.
Significance and novelty: For the first time, absorption studies using modified 
Alternaria toxins in the Caco-2 cell system were carried out.
K E Y W O R D S
alternariol monomethyl ether-glucosides, alternariol-glucosides, Caco-2 cells, In vitro absorption, 
modified mycotoxins, zearalenone-glucosides
2 |   APPEL (KOHN) Et AL.
1 |  INTRODUCTION
Fungi are a natural part of our living environment and can 
infect almost any plant during either growth and/or post-
harvest. A large number of these fungi are also able to form 
mycotoxins, mostly low-molecular metabolites that greatly 
differ in their structures. However, all mycotoxins have in 
common that they are toxic to humans and/or animals even in 
small quantities. Based on in vitro studies with mammalian 
cells, the Alternaria toxins alternariol (AOH) and alterna-
riol monomethyl ether (AME) are assumed to be genotoxic 
(Pfeiffer et  al.,  2007), whereas the Fusarium toxin zeara-
lenone (ZEN) causes reproductive problems in livestock, 
especially in pigs, due to its estrogenic activity (Metzler 
et al., 2010; Zinedine et al., 2007).
These mycotoxins are commonly detected in cere-
als, fruits, and vegetables (Broggi et  al.,  2013; Darsanaki 
et al., 2015; Scott et al., 2012), compromising food and feed 
safety. Modified mycotoxins can be formed by plants in their 
metabolism of xenobiotics, which proceeds in three phases, 
with phase II conjugation reactions being most important. 
Thus, several modified forms of AOH, AME, and ZEN were 
identified in the last decades including glucosides, malo-
nylglucosides, and diglucosides (Engelhardt et  al.,  1988; 
Hildebrand et  al.,  2015; Kamimura,  1986). These phase II 
metabolites are believed to be cleaved during digestion (due 
to the acidic environment in the stomach and small intestine 
or gut microbiota hydrolytic enzymes) releasing the toxic pa-
rental form, thereby contributing to overall toxicity. To carry 
out a risk assessment, the European Food Safety Authority 
(EFSA) requested further data on toxicological effects of 
modified mycotoxins (EFSA, 2014, 2016, 2017).
Detailed knowledge regarding the fate of modified myco-
toxins in the human intestine can be obtained by using cul-
tured Caco-2 cells, representing a widely accepted in vitro 
system to evaluate human intestinal absorption and metab-
olism of various substances (Artursson & Karlsson,  1991; 
Press & Di Grandi,  2008; Yee,  1997). Although they de-
rived from a human colon carcinoma, cultured Caco-2 cells 
have many characteristics of intestinal epithelial cells when 
grown on a permeable membrane under suitable culture con-
ditions for three weeks. Cultured Caco-2 cells form a polar-
ized monolayer with tight junctions between neighboring 
cells. The apical site, being the equivalent of the intestinal 
lumen side, develops microvilli whereas the basolateral site 
represents the blood side of the intestinal epithelium. Also, 
transporter proteins of the ABC superfamily are expressed, 
and various enzymes of phase I and phase II metabolism are 
activated (Press & Di Grandi, 2008).
Recently, the intestinal uptake of ZEN-glucosides and 
glucosidic conjugates of ZEN derivatives (α-/β-ZEL) 
in Caco-2 cells (Cirlini et  al.,  2016; Gratz et  al.,  2017) 
has been studied. Cirlini et  al.  (2016) observed that 
16-O-β-d-glucopyranosyl-ZEN (ZEN16Glc) and 14-O-β-
d-glucopyranosyl-ZEN (ZEN14Glc) pass the Caco-2 cell 
monolayer suggesting a transport from the intestine to the 
portal blood. In contrast, Gratz et  al.  (2017) showed that 
neither ZEN14Glc, nor α- and β-ZEL-14-glucoside (α- and 
β-ZEL14Glc) were absorbed in vitro. These two studies used 
different cell clones of Caco-2 cells as well as different ex-
perimental and culturing conditions, which may explain the 
contradictory results. Both studies have in common that only 
free ZEN was chosen as an indicator for deglucosylation and 
possible phase I and phase II metabolites of the modified my-
cotoxins, formed by the Caco-2 cells, have not been analyzed.
We are not aware of any comparable studies using modi-
fied forms of Alternaria toxins. Because glucosides of AOH 
and AME have been found in various food samples, it is 
important to assess their toxicological potential (Puntscher 
et al., 2018).
Because experimental data on the contribution of mod-
ified mycotoxins to total toxicity are controversy or com-
pletely lacking, in vitro absorption and metabolism studies 
were performed with human Caco-2 cells. Of particular in-
terest was whether the modified forms are absorbed by the 
cells, hydrolyzed resulting in their parental mycotoxins, and 
further metabolized. Mass spectrometric analyses were used 
to examine both the incubation media and the cells for the 
free mycotoxins as well for their metabolites formed by the 
Caco-2 cells. In addition, experiments with the Millicell® 
system were performed to study transport processes (uptake, 
release) in order to predict a potential in vivo absorption.
2 |  MATERIALS AND METHODS
2.1 | Chemicals and reagents
AOH and AME were isolated from a culture of the Alternaria 
alternata strain BFE 1346 grown on rice flour containing 
media for 24 days at 25°C as described earlier for the isolation 
of other Alternaria toxins (Fleck et al., 2012). The crude ex-
tracts of several approaches were analyzed by LC-DAD-MS, 
the extracts were combined, and the fractions containing AOH 
and AME were isolated by preparative HPLC. Evaporated 
and freeze-dried AOH and AME fractions were used for LC-
DAD-MS and NMR analyses. Their identity was confirmed 
by NMR, and the purity was >98% according to HPLC 
analysis with UV detection at 254 nm. ZEN was purchased 
from Fermentek (Jerusalem, Israel) with a purity >98% ac-
cording to the manufacturers´ certificates. HPLC-MS grade 
acetonitrile (ACN) and methanol (MeOH) were purchased 
from VWR International (Bruchsal, Germany). Accutase® 
solution, Lucifer Yellow, and Dulbecco's modified Eagle 
medium (DMEM/F12) was purchased from Sigma-Aldrich 
(St. Louis, USA).
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9-O-β-d-glucopyranosyl-AOH (AOH9Glc), 3-O-β-d- 
glucopyranosyl-AOH (AOH3Glc), 9-O-[β-d-glucopy-
ranosyl(1  →  6)-β-d-glucopyranosyl]AOH (AOH9DiGlc), 
7-O-β-d-glucopyranosyl-AME (AME7Glc), 3-O-β-d-
glucopyranosyl-AME (AME3Glc), ZEN16Glc, and 
ZEN14Glc were isolated from extracts of cells of tobacco 
BY-2 suspension cell cultures that were incubated in the 
presence of AOH, AME, and ZEN as described earlier for 
the isolation of modified Alternaria toxins (Hildebrand 
et  al.,  2015). Mycotoxin conjugates were extracted into 
MeOH/dichloromethane (CH2Cl2) (2/1, v/v), followed 
by MeOH/water/acetic acid (79/20/1, v/v/v), and MeOH/
CH2Cl2 (2/1, v/v) extraction steps. Extracts were freeze-
dried and dissolved in MeOH to isolate modified my-
cotoxins by preparative HPLC. Isolation was performed 
on a reversed phase column (Phenomenex Luna C18(2), 
250 × 15 mm, 5 µm) at a flow rate of 8 ml/min using 0.1% 
formic acid in acetonitrile (A) and 0.1% formic acid (B) in 
water as eluents. Conjugates of AOH and AME were sepa-
rated with initially 80% B, held for 5 min, decreased to 60% 
B within 7 min, held for 6 min, decreased to 0%B, held for 
2 min, and increased to 80% B followed by an equilibration 
step. For separation of ZEN conjugates, the following gra-
dient was used: initially 90% B, decreased to 70% B within 
35 min, decreased to 45% B within 10 min, decreased to 0% 
B within 5 min, held for 5 min, and increased to 90% B fol-
lowed by an equilibration step. Detection was performed at 
254 nm (AOH and AME conjugates) and 280 nm (ZEN con-
jugates). Stock solutions of each conjugate were prepared, 
and their concentrations were determined by quantitative 
1H-NMR using coaxial tubes. Before analyzing sample 
concentrations, relative volumes of the coaxial tubes, and 
T1 times for each compound were determined. Compounds 
were dissolved in DMSO-d6 and added to the outer part of 
coaxial tubes, coaxial inserts contained 150 µl of acetani-
lide (0.3 mg in DMSO-d6) as internal standard. A standard 
Bruker 1H-NMR experiment (zg0) was performed using 
the following parameters: acquisition time 1.6  s, D1 30 s. 
Structure elucidation was performed by applying various 
2D NMR experiments (Hildebrand et al., 2015). Data were 
interpreted individually and, where possible, compared to 
literature data (Borzekowski et al., 2018).
AOH-3-O-sulfate (AOH3S), AOH-9-O-sulfate (AOH9S), 
and AME-3-O-sulfate (AME3S) were available as reference 
compounds from earlier studies with cultured Alternaria al-
ternata strains BFE1346 and BFE1348 (Soukup et al., 2016).
2.2 | Caco-2 cell culture and subculture
Caco-2 cells were from Leibniz Institute DSMZ—
German Collection of Microorganisms and Cell Cultures 
(Braunschweig, Germany; DSMZ No. ACC169). Cells were 
cultured at 37°C and 5% CO2 in plates with 15 cm diameter 
containing 20  ml of medium and initially 1–5  x  106 cells. 
The culture medium consisted of DMEM/F12 with 10% fetal 
calf serum, 100 U/ml penicillin, and 100 mg/ml streptomycin 
and was replaced every 2–3 days. After 7 days, the medium 
was removed and attached cells were washed with 10  ml 
of phosphate-buffered saline (PBS), followed by treatment 
with 2.5  ml of Accutase® solution for 30  s. After removal 
of the Accutase® solution, cells were incubated at 37°C for 
3 min and subsequently suspended in 20 ml of medium. Cell 
number was determined with a Casy® TTC Cell Counter and 
Analyser System (Roche).
2.3 | Stability assay
Stock solutions of AOH, AME, ZEN, AOH3Glc, AOH9Glc, 
AOH9DiGlc, AME3Glc, AME7Glc, ZEN14Glc, and 
ZEN16Glc were prepared in DMSO (approximately 2 mM 
each, depending on the amounts available). These solutions 
were further diluted in Hank´s buffered salt solution (HBSS, 
adjusted to pH 7.5) resulting in mycotoxin concentrations of 
9–21 µM containing 1% DMSO (Figure 1). For the stability 
F I G U R E  1  Concentrations of the stock solutions of the free and 
modified mycotoxins measured by LC-DAD (bar chart). AOH9DiGlc 
is composed of 55.4% of AOH9DiGlc and 44.6% of AOH3Glc. The 
dot plot shows the recovery of the respective substances after 3 hr of 






































































4 |   APPEL (KOHN) Et AL.
assay, the solutions were incubated at 37°C for 3 hr in 24-
well plates and subsequently frozen. As a control, solutions 
were frozen immediately after their production. Samples 
were freeze-dried and redissolved in 100 µl of MeOH for LC-
DAD-MS analyses.
2.4 | Metabolism of the modified mycotoxins 
in Caco-2 cells
Metabolism studies of the modified mycotoxins in dif-
ferentiated Caco-2 cells were performed in 24-well plates 
(Corning® Costar®, 1.9 cm2 surface area). Cells were seeded 
(4 × 105 per well) and grown for 21 days with renewal of 
the medium every 2–3  days. On day 21, medium was re-
moved and 600 µl of mycotoxin solution (20 µM in HBSS, 
1% DMSO) was added. After 3 hr of incubation, the incuba-
tion solution of each well was removed, frozen at −20°C, 
freeze-dried, and redissolved in 100 µl of MeOH for LC-
DAD-MS analysis.
Attached cells of each well were washed twice with 
600 µl of PBS, scraped off with a plastic spatula, suspended 
in 500  µl of purified water, and transferred into a 1.5-ml 
Eppendorf tube. The cells were lysed at −80°C for 24 hr and 
subsequently freeze-dried. For the first extraction of cells, 
500 µl of MeOH/CH2Cl2 (2:1, v/v) was used, whereas 500 µl 
of MeOH/H2O/acetic acid (79/20/1, v/v/v) was used for the 
second extraction, followed by a third extraction with 500 µl 
of MeOH/CH2Cl2 (2:1, v/v). During extraction, samples were 
sonicated in an ultrasonic bath for 5 min each. After centrif-
ugation (3 min at 3,000 g), supernatants were combined and 
evaporated to dryness under a stream of nitrogen. Residues 
were redissolved in 100 µl of MeOH and analyzed by LC-
DAD-MS. The metabolism studies described here were per-
formed in duplicate; variability has been indicated by using 
range/2.
2.5 | Caco-2 Millicell® system: in vitro 
absorption of modified mycotoxins
For absorption experiments (performed in triplicate; preci-
sion indicated by using the standard deviation), 100  µl of 
medium containing 6  ×  105 Caco-2 cells was filled in the 
apical compartment of inserts with semipermeable filters 
(Corning®, 0.33 cm2 surface area, 0.4 µm pore size), whereas 
each well contained 600 µl of medium without cells in the 
basolateral compartment. Cells were grown into a differenti-
ated monolayer for 21 days, with renewal of the medium in 
both compartments every 2–3 days. Then, the medium was 
removed in both compartments, and 100  µl of HBSS con-
taining 20 µM of modified mycotoxin (with 1% DMSO) was 
filled into the apical compartment, whereas 600 µl of HBSS 
was added to the basolateral compartment. After 1 and 3 hr 
of incubation at 37°C, 90 µl of the apical compartment and 
500 µl of the basolateral compartment were transferred to 1.5 
and 2 ml Eppendorf tube, respectively. The solutions were 
freeze-dried and redissolved in 100  µl of MeOH for LC-
DAD-MS analyses.
2.6 | Integrity of cell monolayers
In order to verify the integrity of the cell monolayer, both 
compartments were washed twice with HBSS directly after 
the absorption experiment, and 60 µl of Lucifer Yellow so-
lution (100  µg/ml in HBSS) was added to the apical com-
partment, whereas the basolateral compartment contained 
dye-free HBSS. After an incubation period of 1 hr at 37°C, 
200 μl of the basolateral solution was removed twice for du-
plicate fluorimetrical Lucifer Yellow analysis (excitation at 
485 nm and emission at 535 nm). Only cell layers with less 
than 2% transfer of the dye from the apical to the basolateral 
side were considered intact (Debebe et al., 2012).
2.7 | LC-DAD-MS analysis
An LXQ Linear Ion Trap MSn system (Thermo Fisher 
Scientific, Waltham, MA, USA) equipped with a Finnigan 
Surveyor HPLC-DAD system was used for LC-DAD-MS 
analysis. Separation was carried out on a reversed phase col-
umn (Phenomenex Luna, C18(2), 5 µm, 100 Å, 250 × 4.6 mm 
i.d.). Solvent A was H2O containing 5  mM ammonium ac-
etate, and solvent B was ACN with 0.1% formic acid, and the 
flow rate was 0.5 ml/min. To analyze AOH, AME, and their 
derivatives, the linear gradient started with 20% B, was held 
for 5 min, was ramped to 50% B in 10 min, was ramped to 
70% B in 9 min, reached 100% B within 5 min, was held for 
2 min, and was decreased to 20% B in 1 min, and the sys-
tem was equilibrated for 3 min before the next sample was 
injected. To analyze ZEN and its derivatives, the linear gradi-
ent started with 10% B, was ramped to 31% in 23 min, was 
ramped to 55% B in 10 min, was ramped to 100% B in 4 min, 
was held for 8 min, and was decreased to 10% B in 2 min, and 
the system was equilibrated for 5 min before the next sam-
ple was injected. The detection wavelength was 254 nm for 
AOH, AME, and their conjugates/metabolites, and 280 nm for 
ZEN and its derivatives/metabolites. UV absorbance at these 
wavelengths was used for quantification using external cali-
bration curves of the parental mycotoxins (lowest calibration 
point was set as limit of quantification: AOH/AME = 1 µM, 
ZEN = 3 µM), assuming the same molar coefficient for the 
free mycotoxins and their conjugated metabolites. Because 
the absorption properties of the free mycotoxins, the modi-
fied mycotoxins (plant based), and the mycotoxin metabolites 
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(Caco-2 cell based) may more or less strongly deviate, this ap-
proach is semiquantitative only, depending on the application. 
This needs to be considered when, for example, recoveries are 
assessed for experiments, in which (modified) mycotoxins are 
further metabolized.
The mass spectrometer was operated in the negative electro-
spray ionization (ESI) mode for all mycotoxins. For the analy-
ses of ZEN and its derivatives/metabolites, nitrogen was used as 
sheath gas, auxiliary gas, and sweep gas with flow rates of 26.0, 
15.0, and 0.02 L/min, respectively. Spray voltage was 4.00 kV, 
spray current 3.15 µA, capillary voltage 45.10 V, capillary tem-
perature 350°C, and the tube lens voltage was 125.59 V. To an-
alyze AOH, AME, and their conjugates/metabolites, nitrogen 
was used as sheath gas, auxiliary gas, and sweep gas with flow 
rates of 9.0, 29.0, and 0.02 L/min, respectively. Spray voltage 
was 4.00 kV, spray current 3.15 µA, capillary voltage 45.10 V, 
capillary temperature 350°C, and the tube lens voltage was 
125.49 V. Full scan mass spectra for all mycotoxins were re-
corded from m/z 100 to 800 in order to confirm the identity of 
the compounds by determining their [M – H]− ions. A signal to 
noise ratio (S/N) of 3 was used to decide whether a compound 
was detectable (S/N ≥ 3) or not (S/N < 3).
2.8 | Calculation of Papp
Papp values were calculated according to Artursson and 
Karlsson (1991) using the formula.
where Q is the amount of substance (µmol) in the basolateral 
compartment (either parental compound or the sum of the pa-
rental compound and metabolites), t the incubation time (s), 
A the surface area of the monolayer (0.33 cm2), and capi the 
initial concentration (mmol/L) of the mycotoxin in the apical 
compartment.
3 |  RESULTS
3.1 | Stability assay of the modified 
mycotoxins
Because reference substances of glucosides of AOH, AME, and 
ZEN were not commercially available, small amounts of these 
mycotoxins were isolated of plant cell extracts (Hildebrand 
et al., 2015). Modified mycotoxins and their aglycones AOH, 
AME, and ZEN were first completely solubilized in DMSO, 
further diluted in HBSS solution (mycotoxin concentrations 
9–21 µM, 1% DMSO), and incubated at conditions used during 
metabolism and adsorption studies. Free mycotoxins and their 
glucosides showed recovery rates of 88%–100% after 3 hr of 
incubation at 37°C (Figure 1). Thus, they are sufficiently sta-
ble for metabolism and absorption experiments. Minor losses 
may be due to reduced solubility of some compounds in HBSS, 
resulting in incompletely dissolved compounds that are avail-
able for further experiments. However, it should be considered 
that undissolved mycotoxins or modified mycotoxins can be 
redissolved during the Caco-2 cell experiments if some of the 
dissolved compound has been metabolized. This may result in 
slight over- or underestimations.
Furthermore, it was found that the solution of AOH9DiGlc 
was contaminated with AOH3Glc. The solution was com-
posed of 55.4% AOH9DiGlc and 44.6% AOH3Glc, which 
was considered in the following experiments.
3.2 | Uptake and metabolism in Caco-2 cells
To investigate the metabolism of modified forms of AOH, 
AME, and ZEN, Caco-2 cell monolayers were grown on 24 
well plates and treated with modified mycotoxins in solution 
(in HBSS, 1% DMSO) at 37°C for 3 hr. As positive control, 
cells were incubated with free mycotoxins, whereas incuba-
tions with HBSS containing 1% DMSO served as negative 
control. Supernatants and cell lysates were analyzed for free 
and modified mycotoxins as well as for metabolites formed 
by Caco-2 cells.
3.2.1 | Free mycotoxins AOH, 
AME, and ZEN
The HPLC-DAD chromatograms of supernatants and cell 
lysates resulting from incubations with unconjugated myco-
toxins are shown in Figure 2. AOH, AME, and ZEN were 
taken up into the cells. Several metabolites of the free my-
cotoxins were identified by LC-MS analyses mainly in the 
supernatant, which is in accordance with earlier findings 
(Burkhardt et  al.,  2009; Pfeiffer et  al.,  2011). Metabolites 
were characterized as monosulfates and glucuronides of 
AOH, AME, and ZEN, and as reductive metabolites of ZEN 
by their [M–H]− quasi molecular ions in the negative mode 
ESI mass spectra and by the characteristic release of the pa-
rental mycotoxin in MS2 spectra (Table 1). The distribution 
of (semi-)quantifiable metabolites in both the supernatant 
and in the cells is shown in Figures 3–5.
Assignment of the linkage position of the metabolites 
and of the stereoisomers of the reductive derivatives of ZEN 
were either made tentatively based on their chromatographic 
properties and by comparison with literature data (Burkhardt 
et al., 2009; Pfeiffer et al., 2011) or in case of AOH and AME 
sulfates by comparison with reference compounds. However, 
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the linkage position of the glucuronides. Because most of the 
metabolites were found in the supernatant (Figures 3–5), it 
can be suggested that the free mycotoxins were absorbed, me-
tabolized, and subsequently transported to the extracellular 
space. This is consistent with results published by Burkhardt 
et al. (2009). The authors also found larger amounts of me-
tabolites in the supernatant, whereas mainly the nonmetabo-
lized toxins were present in the cells.
To assess the data from a quantitative point of view, it 
has to be noted that the sum of the recovered AOH, AME, 
ZEN, and their metabolites were 39.1 ± 1.1%, 50.5 ± 5.9%, 
and 38.6 ± 0.9%, respectively. These comparably low recov-
ery rates may be due to an incomplete cell extraction, the 
poor solubility of the mycotoxins or analytical limitations 
based on quantitation at 254 nm (AOH, AME, and their me-
tabolites) and 280 nm (ZEN and its metabolites) assuming 
a similar extinction coefficient of the metabolites and their 
parental mycotoxin. Additionally, formation of unknown 
metabolites is possible, but they are not expected to largely 
affect recovery rates. However, from a qualitative point of 
view, the metabolism of the free mycotoxins was comparable 
to previous publications.
3.2.2 | Modified forms of AOH, 
AME, and ZEN
AOH conjugates
Incubation of Caco-2 cells with AOH9Glc resulted in a 
similar metabolite distribution compared to the metabolite 
pattern of unmodified AOH (Figure 3). After 3 hr of incuba-
tion, AOH9Glc from the supernatant still represented 45% of 
the recovered compounds. In general, most of the metabo-
lites were found in the supernatant, too, including AOH-3-
glucuronide (AOH3GlcA) (15% of the recovered compounds), 
AOH-9-glucuronide (AOH9GlcA) (11% of the recovered 
compounds), AOH3S (14% of the recovered compounds), 
and unconjugated AOH (8% of the recovered compounds). In 
F I G U R E  2  HPLC-profiles of the extracts of the culture media and the cell extracts of Caco-2 cells incubated with AOH (a), AME (b), and 
ZEN (c) for 3 hr. Identification of metabolites was done by LC-MS analyses. Structure characterization has been tentative based on literature data 
(Burkhardt et al., 2009; Pfeiffer et al., 2011). To identify AOH and AME sulfates, reference compounds were available



















































































































T A B L E  1  Characterization of monoglucuronides (GlcA) and monosulfates (S) of AOH, AME, ZEN and, reductive metabolites of ZEN by 






















AOH 22.6 257 3-O-GlcA 15.1 433 257 3-O-S 20.6 337 257
9-O-GlcA 14.3 433 257
AME 28.6 271 3-O-GlcA 18.7 447 271 3-O-S 25.7 351 271
7-O-GlcA 15.4 447 271
ZEN 22.0 317 14-O-GlcA 11.4 493 317
α-ZEL 18.6 319 14-O-GlcA 9.6 495 319 14-O-S 14.9 399 319
β-ZEL 16.5 319 14-O-GlcA 8.5 495 319
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the cells, AOH was present in quantifiable amounts besides 
traces of the two AOH-glucuronides and AOH9Glc. Thus, 
AOH9Glc was absorbed from the Caco-2 cells, degluco-
sylated to AOH, and further (partially) metabolized followed 
by an excretion of metabolites and AOH. This observation 
may support the hypothesis that modified mycotoxins con-
tribute to overall toxicity of mycotoxins. However, it should 
be noted again that the sum of the recovered compounds was 
only 65.3 ± 6.3% of the initial amount of AOH9Glc.
Incubation of Caco-2 cells with AOH3Glc resulted in a 
different metabolite distribution compared to incubation with 
AOH9Glc. Again, most of the metabolites were identified in 
the supernatant. The plant metabolite AOH3Glc (in the su-
pernatant) made up 90% of the total sum of the recovered 
metabolites. In addition, AOH3GlcA (5% of the recovered 
compounds), AOH9GlcA (2% of the recovered compounds), 
and AOH3S (2% of the recovered compounds) were (semi-)
quantitated in the supernatant. Free AOH was detected in 
traces both in the supernatant and in the cells. In addition, 
small amounts of AOH3Glc were quantified in the cells to-
gether with traces of AOH3GlcA and AOH9GlcA. The sum 
of all quantifiable metabolites was 71.4 ± 1.9% of the initial 
amount of AOH3Glc. These data suggest that AOH3Glc is 
also absorbed, deglucosylated, and further metabolized, but 
to a considerably lesser extent than AOH9Glc. It can thus be 
assumed that the position of the glucosylation has an impact 
on the absorption and metabolism of modified mycotoxins in 
Caco-2 cells.
Metabolism studies with the mixture of AOH9DiGlc and 
AOH3Glc pointed out that no significant absorption, deglu-
cosylation and/or metabolization occurred in Caco-2 cells. 
Only traces of AOH9DiGlc (and AOH3Glc) were detected in 
the cells, indicating a minor absorption of AOH9DiGlc (and 
AOH3Glc). Therefore, it can be suggested that mycotoxins 
carrying a disaccharide group are absorbed less efficiently 
than mycotoxins carrying a monosaccharide group. However, 
traces of AOH9Glc were found in the supernatant indicat-
ing a partial cleavage of AOH9DiGlc. Because AOH3Glc 
remained mainly intact in the supernatant in the individual 
experiment, this is consistent with the results of the com-
bined experiment with AOH9DiGlc. The total recovery was 
85.9 ± 5.4% of the initial applied compounds.
AME conjugates
Figure 4 provides an overview of the metabolism of AME7Glc 
and AME3Glc in Caco-2 cells compared to the metabolism of 
free AME. After incubation of the Caco-2 cells with AME7Glc 
for 3 hr, mostly AME7Glc was quantitated in the supernatant 
(80% of all recovered compounds), followed by AME-3-
glucuronide (AME3GlcA) (12% of the recovered compounds) 
and AME3S (5% of the recovered compounds), whereas the 
F I G U R E  3  Relative distribution of quantifiable compounds in 
the supernatant (filled bars) and in the extracted Caco-2 cells (shaded 
bars) after incubation of the cells with AOH, AOH9Glc, AOH3Glc, 
and AOH9DiGlc in 24-well plates for 3 hr (n = 2; range/2). It has 
to be mentioned that recoveries of AOH, AOH9Glc, AOH3Glc, and 
AOH9DiGlc including their identified metabolites were 39.1 ± 1.1%, 




























































F I G U R E  4  Relative distribution of quantifiable compounds in 
the supernatant (filled bars) and in the extracted Caco-2 cells (shaded 
bars) after incubation of the cells in the presence of AME, AME3Glc, 
and AME7Glc in 24-well plates for 3 hr (n = 2; range/2). It has to be 
mentioned that the recoveries of AME, AME3Glc, and AME7Glc 
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aglycone AME was only detected in traces. Differently, how-
ever, AME was present in quantifiable amounts in the cells. In 
addition, AME7Glc, AME3GlcA, and AME3S were detected. 
The sum of all quantifiable metabolites was 92.6 ± 7.5% of 
the initially applied amount of AME7Glc.
A comparable distribution of metabolites was obtained 
after incubation of Caco-2 cells with AME3Glc. The major-
ity (82%) of the recovered compounds was in form of the 
initial modified mycotoxin in the medium. Additionally, 
AME3GlcA (9% of the recovered compounds), AME3S (4% 
of the recovered compounds), and AME (2% of the recovered 
compounds) were quantified in the supernatant. AME3Glc, 
its aglycone AME, and traces of AME3GlcA were identified 
intracellularly, indicating the absorption, deglucosylation, 
and metabolization of AME3Glc in Caco-2 cells. The recov-
ery of all compounds in the supernatant and in the cells was 
109.7 ± 3.9% of the initially used amount of AME3Glc.
ZEN conjugates
In contrast to AOH- and AME-glucosides, the parental my-
cotoxin ZEN or ZEN metabolites were not detected in quan-
tifiable amounts after 3 hr of incubation of ZEN-glucosides, 
neither in the cells nor in the medium (Figure 5). Nevertheless, 
traces of ZEN-14-glucuronide (ZEN14GlcA), ZEN-14-sulfate 
(ZEN14S), and α-ZEL-14-sulfate (α-ZEL14S) were detected 
after incubation of Caco-2 cells with ZEN14Glc, whereas only 
one sample of duplicate experiments with ZEN16Glc showed 
traces of ZEN14GlcA. However, it has to be mentioned that 
the overall recovery in the experiment with ZEN14Glc was 
117.2 ± 4.6%, whereas recovery after incubation of ZEN16Glc 
was only 33.3 ± 3.3% of the initially applied ZEN glucoside. 
Therefore, the results of the experiment using ZEN16Glc have 
to be interpreted with caution. However, it appears reason-
able to assume that the two glucosides of ZEN were absorbed, 
cleaved, and metabolized by Caco-2 cells to a lesser extent 
compared to AOH- and AME-glucosides.
3.3 | Absorption and metabolism in the 
Caco-2 Millicell® system
The Caco-2 Millicell® system is a well-established in vitro 
model to study the transition of compounds from the apical 
site to the basolateral site. Caco-2 cells were cultured in tran-
swell inserts on semipermeable membranes, and the apical 
region was incubated for 1 or 3 hr at 37°C with the free my-
cotoxins AOH, AME, and ZEN (as control experiments) and 
with their glucosylated forms. After incubation, both the api-
cal and the basolateral medium were removed and analyzed 
by LC-DAD-MS. The concentrations of AOH, AME, ZEN, 
and their Caco-2 metabolites (glucuronides and sulfates) 
were semiquantitatively determined using external calibra-
tions calculated with the free mycotoxins. The integrity of the 
cell monolayer was tested as described above and evaluated 
by using previously described criteria (Debebe et al., 2012).
3.3.1 | Free mycotoxins AOH, 
AME, and ZEN
For comparison and to better evaluate the results of the modi-
fied mycotoxins, the absorption of the free mycotoxins AOH, 
AME, and ZEN was analyzed, too. The results of 1 and 3 hr 
incubations with AOH, AME, and ZEN (Table 2) are quali-
tatively comparable to previously published data (Burkhardt 
et al., 2009; Pfeiffer et al., 2011).
AOH
After 1 hr of incubation with AOH, the Caco-2 metabolite 
AOH3S and unconjugated AOH were detected in the api-
cal compartment, whereas no metabolites or free AOH were 
identified in the basolateral compartment. However, total re-
covery was only 22%, which may be due to the fact that intra-
cellular concentration was not measured in this assay. After 
incubation for 3  hr, AOH9GlcA, AOH3GlcA, and AOH3S 
were determined in the apical compartment. Traces of the 
two AOH-glucuronides, AOH3S, and parental AOH were 
detected in the basolateral compartment. The overall recov-
ery was 35%, which is approximately equivalent to the recov-
ery rate in the supernatant in the metabolism experiment. The 
results indicate a time-dependent absorption, metabolization, 
F I G U R E  5  Relative distribution of quantifiable compounds in 
the supernatant (filled bars) and in the extracted Caco-2 cells (shaded 
bars) after incubation of the cells in the presence of ZEN, ZEN14Glc, 
and ZEN16Glc in 24-well plates for 3 hr (n = 2; range/2). It has to 
be mentioned that the recoveries of ZEN, ZEN14Glc, and ZEN16Glc 
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and excretion (to the apical and basolateral compartment) of 
AOH/AOH metabolites by Caco-2 cells.
AME
Incubation of Caco-2 cells for 1  hr with AME resulted in 
a very low total recovery of 15% (including compounds in 
the apical and basolateral compartment), and only AME was 
quantified in the apical compartment. In addition, traces of 
AME3GlcA and AME3S were detected in the apical com-
partment. Only traces of AME3GlcA were detected basolat-
erally. With increasing incubation time, the concentration of 
AME in the apical compartment decreased to nonquantifiable 
amounts, accompanied by an increase of AME3GlcA and 
AME3S concentrations, and the detection of AME7GlcA. 
Additionally, it was possible to detect AME7GlcA (next to 
AME3GlcA) in the basolateral compartment, suggesting 
a time-dependent resorption of AME in Caco-2 cells, too. 
Overall recovery (including compounds in the apical and 
basolateral compartment) in the 3 hr experiment was 40% of 
the initially applied AME amount.
ZEN
The absorption studies with ZEN (both after 1 and 3 hr of incu-
bation) resulted in detectable, but not in quantifiable amounts 
of ZEN and its main metabolites ZEN14GlcA, ZEN14S, and 
α-ZEL14S. All of them were present in apical and basolat-
eral compartments, with the exception of α-ZEL14S, which 
was not detected in the basolateral compartment after 1 hr of 
incubation. The amount of initially used ZEN was “distrib-
uted” over several newly formed metabolites and quantita-
tion was not possible (and therefore the determination of a 
recovery rate; artificially set to 0% in Table 2). Nevertheless, 
it can be assumed that small amounts of ZEN are absorbed by 
Caco-2 cells, metabolized, and transported to the basolateral 
compartment.
3.3.2 | Modified forms of AOH, 
AME, and ZEN
Results of the in vitro absorption studies of the modified my-
cotoxins in the Caco-2 Millicell® system are summarized in 
Table  3. The overall recoveries in the various experiments 
were between 30% and 77%. Low recoveries may result from 
intracellular localization of metabolites and/or from ana-
lytical limitations (see Section 2.7). However, as results of 
absorption studies with unconjugated mycotoxins are qual-
itatively comparable to literature data, the test system was 
considered appropriate.
AOH glucosides and AOH diglucoside
Absorption studies in Caco-2 cells revealed that AOH9Glc 
was absorbed and deglucosylated by Caco-2 cells resulting 
in the detection of AOH in the basolateral compartment after 
T A B L E  2  Results of the absorption studies (mean ± standard deviation; n = 3) with the Millicell® system after incubation of the Caco-2 cells 
in the presence of AOH, AME, and ZEN
Substance
Applied 
amount (nmol) t Compartment Amount (nmol) Recovery (%)
AOH AOH9GlcA AOH3GlcA AOH3S
AOH 1.69 1 hr Apical 0.23 ± 0.04 nd nd 0.15 ± 0.04 22
Basolateral nd nd nd nd
3 hr Apical nd 0.20 ± 0.06 0.22 ± 0.06 0.17 ± 0.05 35
Basolateral nq nq nq nq
AME AME7GlcA AME3GlcA AME3S
AME 1.48 1 hr Apical 0.22 ± 0.04 nd nq nq 15
Basolateral nd nd nq nd
3 hr Apical nq nq 0.39 ± 0.09 0.20 ± 0.03 40
Basolateral nd nq nq nd
ZEN ZEN14GlcA ZEN14S α-ZEL14S
ZEN 1.52 1 hr Apical nq nq nq nq 0a 
Basolateral nq nq nq nd
3 hr Apical nq nq nq nq 0 a 
Basolateral nq nq nq nq
Abbreviations: t, incubation time; DiGlc, diglucoside; Glc, glucoside; GlcA, glucuronide; S, sulfate; nd, not detectable; nq, detected, but not quantifiable
aCalculation of recovery rates was not possible due to nonquantifiable amounts of identified compounds. 
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both 1 and 3 hr of incubation. Unconjugated AOH was present 
in a quantifiable amount after 1 hr of incubation in the apical 
compartment, too. The only metabolite detected in the apical 
compartment after 1 hr of incubation was AOH3S. Longer 
incubation time resulted in further metabolization of AOH 
to AOH9GlcA and AOH3GlcA, which were identified in 
both compartments. In contrast, incubations with AOH3Glc 
for 1 and 3 hr resulted in the formation of AOH and AOH 
metabolites present only in the apical compartment, with the 
exception of AOH3GlcA that was detected in the basolateral 
compartment after 3 hr of incubation, too.
The results show that monoglucosylated AOH is absorbed 
time-dependently by Caco-2 cells, deglucosylated to AOH, 
and further metabolized to glucuronides and sulfates, which 
are also excreted to the basolateral site, indicating a potential 
intestinal absorption of monoglucosylated AOH with AOH 
conjugates reaching the portal blood.
Incubation of Caco-2 cells for 1  hr with a mixture of 
AOH9DiGlc and AOH3Glc did not result in a transition 
of compounds into the basolateral compartment, but small 
amounts of AOH and AOH3S were detected in the apical 
compartment. Longer incubation time induced the additional 
formation of AOH-glucuronides, which were both detected in 
the apical and basolateral compartment. Because the incuba-
tion solution was composed of AOH9DiGlc and AOH3Glc, 
it cannot be concluded that AOH9DiGlc contributed to these 
findings. However, metabolism studies using AOH9DiGlc 
showed the formation of AOH9Glc that indicates a hydroly-
sis of the diglucoside suggesting at least a (minor) contribu-
tion of AOH9DiGlc to the presence of AOH metabolites in 
the basolateral compartment.
AME-glucosides
Besides modified forms of AOH, glucosides of AME were 
studied for their potential epithelial transport. After 1 hr of 
incubation with AME7Glc, 51% of the initial compound 
was determined in the apical compartment, next to traces of 
AME, AME3GlcA, and AME3S. However, AME and AME 
metabolites were not detected in the basolateral compart-
ment. Incubation for 3  hr resulted in the identification of 
AME3GlcA and AME3S in the basolateral compartment, 
too. Similarly, the plant metabolite AME3Glc did not cross 
the Caco-2 monolayer after 1  hr of incubation, whereas 
AME3GlcA was detected in the basolateral compartment 
after 3 hr of incubation. The results suggest a time-dependent 
absorption, deglucosylation, and metabolization of the two 
AME-glucosides, and excretion of metabolites formed by the 
Caco-2 cells to the basolateral site.
ZEN-glucosides
Absorption studies using glucosylated ZEN showed that 
ZEN14Glc was absorbed, cleaved, and metabolized to 
ZEN14S and α-ZEL14S after 1  hr of incubation, which 
were both detected in the apical compartment. Additionally, 
traces of ZEN and ZEN14GlcA were found in the apical 
compartment after 3 hr of incubation, but neither unconju-
gated ZEN nor ZEN metabolites were detected on the baso-
lateral site. The initial compounds were recovered to 62 and 
70% in the apical compartment. In comparison, ZEN16Glc 
was recovered to 75 and 71% of the initial amount in the 
apical compartment after 1 and 3 hr of incubation, respec-
tively, but no metabolites were detected either in the apical 
or in the basolateral compartment. In accordance with the 
metabolism experiments, no significant release of ZEN or 
formation of ZEN metabolites occurred after incubation of 
Caco-2 cells for 3 hr with ZEN14Glc and ZEN16Glc. Both 
conjugates seem to be absorbed by Caco-2 cells to a minor 
extent only.
3.4 | Apparent permeability coefficient 
Papp of modified AOH, AME, and ZEN
Papp values express the transition of a compound from 
the apical to the basolateral compartment in the Caco-2 
Millicell® system. The correlation between Papp values 
from Caco-2 studies and the absorption rate after oral up-
take in humans has been investigated on numerous sub-
stances with different structural properties (Artursson & 
Karlsson, 1991; Press & Di Grandi, 2008; Yee, 1997). Papp 
values below 1  ×  10−6  cm/s implicate a poor absorption 
(0%–20%), whereas Papp values between 1–10 × 10
−6 cm/s 
indicate a moderate absorption (20%–70%), and Papp val-
ues over 10 × 10−6 cm/s a well absorption (70%–100%) of 
the corresponding compound (Yee, 1997). In this study, it 
was only possible to calculate Papp values for AOH3Glc 
and AME7Glc. Papp values of other modified mycotoxins 
could not be calculated because quantitation of metabolites 
in the basolateral compartment was not possible. The cal-
culated Papp values in this study were 2.1 × 10
−6 cm/s for 
AOH3Glc and 1.7 × 10−6 cm/s for AME7Glc. Therefore, 
the absorption of the two glucosylated Alternaria toxins is 
assumed to be moderately, and an intake of these modified 
mycotoxins should not be underestimated. However, it has 
to be taken into account that calculation of Papp values does 
not consider compounds that were detected in nonquantifi-
able amounts.
4 |  DISCUSSION
Data gathered here provide insights into the bioavailability of 
modified mycotoxins because predictions about the epithelial 
transition can be made. Metabolism studies with glucosidic 
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metabolites of AOH and AME showed that the monogluco-
sides were taken up by Caco-2 cells, deglucosylated, and fur-
ther metabolized to glucuronides and sulfates with AOH9Glc 
being metabolized to a higher extent than glucosides of AOH 
or AME linked at positions 3 or 7. Although no metabo-
lites were quantified after incubation of Caco-2 cells with 
AOH9DiGlc, the detection of AOH9Glc indicates a slight 
hydrolysis of the diglucoside.
Further absorption studies indicate a possible in-
testinal transition of glucosylated AOH and AME in 
form of their aglycones as well as glucuronides and sul-
fates to the portal blood. In particular, AOH, AME, and 
their Caco-2 metabolites were identified in the baso-
lateral compartment after 1 and/or 3  hr of incubation. 
Metabolites identified in the basolateral compartment 
were equivalent to the metabolites identified after incu-
bation of the Caco-2 Millicell® system with unconjugated 
mycotoxins.
For the free mycotoxins AOH and AME, Papp values 
of 34.9 × 10−6  cm/s and 10.3 × 10−6  cm/s were described 
in literature (Burkhardt et al., 2009), but could not be con-
firmed in this study because free mycotoxins and their me-
tabolites were present in the basolateral compartment in 
concentrations below the limit of quantitation. However, 
Papp values of AOH3Glc (2.1 × 10
−6  cm/s) and AME7Glc 
(1.7 × 10−6 cm/s) were calculated, which are lower compared 
to the Papp values of their aglycones described in literature. 
Therefore, it can be suggested that absorption of both modi-
fied mycotoxins is lower as compared to unconjugated AOH 
and AME. However, our calculation of Papp values has some 
limitations, for example low recovery rates and nonquantifi-
able amounts of compounds in the basolateral compartment. 
In addition, comparison of our values with literature data is 
limited because different cell culture conditions may result 
in (minor) deviations. Nevertheless, the two glucosylated 
Alternaria toxins appear to be absorbed and should therefore 
be taken into account in the risk assessment of food and feed 
(Yee, 1997).
Metabolism studies of ZEN14Glc and ZEN16Glc in 
Caco-2 cells showed that both glucosides were absorbed 
and metabolized only to a small extent. In contrast to the 
experiments with modified Alternaria toxins, neither de-
tectable unconjugated ZEN nor detectable ZEN metabolites 
were transported to the basolateral site within the experi-
mental time frame. Nevertheless, our results indicate that 
the bioavailability of ZEN-glucosides is considerably lower 
than the bioavailability of unconjugated ZEN. In literature, 
studies with plant-based phase  II metabolites of ZEN are 
contradictory concerning the intestinal absorption. In accor-
dance with our data, Gratz et al. (2017) demonstrated that 
ZEN14Glc, α-ZEL14Glc, and β-ZEL14Glc were almost 
fully recovered (91%–93%) from the apical compartment 
after 24 hr of incubation, and only traces of ZEN14Glc and 
α-ZEL14Glc were detected on the basolateral compartment 
after 6 and 24  hr. Therefore, they concluded that limited 
bioavailability of glucose bound zearalenone compounds 
can be assumed. Contrary, however, Cirlini et  al.  (2016) 
observed that ZEN14Glc and ZEN16Glc were absorbed by 
Caco-2 cells and deglucosylated to ZEN, which was fur-
ther transported to the basolateral compartment. Therefore, 
they suggested a possible intestinal absorption of the two 
glucosylated forms of ZEN, although ZEN16Glc seemed 
to be absorbed and deglucosylated to a lesser degree than 
ZEN14Glc. Such variabilities in cell culture studies can be 
attributed to various factors such as different concentration 
levels, Caco-2 cell clones, cell culture conditions (passage 
number, medium, pH, usage of fetal bovine serum, integrity 
of the cells, DMSO concentration), and analytical meth-
ods (Press & Di Grandi, 2008). However, none of the two 
studies analyzed possible Caco-2 metabolites (glucuronides 
and sulfates). In the current study, sulfates and glucuron-
ides of ZEN were identified, however, not in the basolateral 
compartment.
Besides the in vitro studies with modified ZEN, in vivo 
studies with pigs have been carried out, too, indicating that 
modified forms of ZEN were hydrolyzed during digestion, 
thereby contributing to the overall toxicity of ZEN (Binder 
et al., 2017; Catteuw et al., 2019; Gareis et al., 1990). Also, 
the behavior of modified ZEN in the presence of fecal batch 
cultures was studied, demonstrating a rapid hydrolysis of 
ZEN- and α/β-ZEL-glucosides by the human colonic mi-
crobiota (Dall'Erta et al., 2013; Gratz et al., 2017; Kovalsky 
Paris et al., 2014). These studies indicate that other degluco-
sylation routes need to be considered for the risk assessment 
of modified mycotoxins, too, especially for ZEN-glucosides, 
which were deglucosylated by Caco-2 cells only to a minor 
extent.
5 |  CONCLUSION
It was shown for the first time that plant-based phase II 
metabolites of AOH and AME are absorbed and further 
metabolized by Caco-2 cells, which implicates a possible 
in vivo absorption in the intestine of humans or animals, 
resulting in a potential contribution of modified Alternaria 
toxins to overall toxicity. Therefore, they should be con-
sidered in further studies for risk assessment of modified 
mycotoxins. In contrast, our results show that ZEN-
glucosides are absorbed and metabolized to a lesser ex-
tent by Caco-2 cells, suggesting a lower bioavailability 
compared to modified Alternaria toxins and unconjugated 
ZEN itself.
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